Skip to content

Author

A. Nielsen

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 16691: High-Dose versus Standard-Dose Influenza Vaccine in Older Adults with Neurological and Cerebrovascular Disease: A Prespecified Analysis of the DANFLU-2 Trial

Background: Adults with neurological or cerebrovascular (NeCVD) disease have an elevated risk of influenza-related complications. Whether HD-IIV provides greater relative benefit over SD-IIV in this population is uncertain. Objective: To evaluate the relative vaccine effectiveness (rVE) of high-dose inactivate...

M. Yafasov, N. Johansen, D. Modin et al. · 0 citations
Open access Oct 2026

Left atrial function and risk of heart failure in the general population

While impaired left atrial (LA) function has been linked to an increased risk of cardiovascular outcomes, recent investigations has focused on LA longitudinal strain. However, data are limited on which LA functional parameter provides the strongest prognostic information regarding the long-term risk of incident h...

A. Nielsen, K. Skaarup, R. Hauser et al. · 0 citations
Open access Oct 2026

Left atrial reservoir strain, cardiac dysfunction and outcomes in acute heart failure

The clinical relevance of left atrial (LA) dysfunction in acute heart failure (AHF) is unclear. Whether LA strain reflects disease mechanisms and predicts adverse outcomes in this heterogeneous population remains insufficiently investigated. The aim was to examine the relationships between LA reservoir str...

M. Pedersen, F. Davidovski, C. Espersen et al. · 0 citations
Oct 2026

Effect of Colchicine on Arterial Stiffness in Patients With Hypertension: The COlchicine HypERtENsion Trial (COHERENT).

AIM This trial investigated whether colchicine, an anti-inflammatory treatment, affects cardiovascular structure and function, assessed by arterial stiffness, blood pressure and biochemistry, compared with placebo. METHODS COHERENT was a randomized, double-blind, placebo-controlled trial of the effects of colchicine...

A. Langhoff, N. Johansen, K. Bartholdy et al. · 0 citations
Aug 2026

Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults.

BACKGROUND Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...

M. Lassen, S. Christensen, M. Yafasov et al. · 1 citation
Open access 2027

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...

C. Espersen, N. Johansen, D. Modin et al. · 0 citations
#protein folding Open access Oct 2026

RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial.

In adults aged 60 years or older, RSVpreF vaccination reduced hospitalisations for RSV-related respiratory tract disease with no statistical evidence of effect modification by immunosuppression status; however, the study was not powered to exclude subgroup differences.

A. Reimer Jensen, M. H. Højbjerg Lassen, N. Johansen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.